N,N-diethyl-1,2-cyclohexanediamine | 91015-20-2

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N,N-diethyl-1,2-cyclohexanediamine
• 英文别名: 2-(diethylamino)-cyclohexylamine；1,2-Cyclohexanediamine, N1,N1-diethyl-；2-N,2-N-diethylcyclohexane-1,2-diamine
• CAS: 91015-20-2
• 化学式: C₁₀H₂₂N₂
• 分子量: 170.298
• InChiKey: VTVCXLUDVDCEBU-UHFFFAOYSA-N

物化性质

• 沸点：
  102 °C(Press: 13 Torr)
• 密度：
  0.91±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N,N-diethyl-1,2-cyclohexanediamine 生成 trans-2-(N-pyrrolidinyl)cyclohexylamine
  参考文献：
  名称：

  Method of treating chloroquine-resistant malaria with aminoquinoline

  摘要：

  描述了一种一般式为##STR1##的新型氨喹啉衍生物。还描述了一种治疗疟疾病原体的方法，特别是使用式I化合物或其药用可接受盐和可水解酯治疗氯喹耐药性疟疾病原体。

  公开号：

  US05596002A1

文献信息

• [EN] INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS DE L'INDOLE
  申请人：LUNDBECK & CO AS H

  公开号：WO2009120655A1

  公开（公告）日：2009-10-01

  The present invention relates to indole derivatives which bind to the MCHl receptor. In separate aspects, the subject invention is directed to uses of said compounds in the preparation of a pharmaceutical composition for the treatment of obesity and CNS related disorders and to methods of treating said disorders comprising administering a therapeutically effective amount of a compound of the invention.

  本发明涉及能够结合MCH1受体的吲哚衍生物。在不同的方面，本发明涉及这些化合物在制备用于治疗肥胖和中枢神经系统相关疾病的药物组合物中的用途，以及包括给予本发明化合物有效治疗量的治疗这些疾病的方法。
• Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides - new selective class III agents
  作者：Thomas K. Morgan、Randall Lis、William C. Lumma、Klaus Nickisch、Ronald A. Wohl、Gary B. Phillips、Robert P. Gomez、John W. Lampe、Susan V. Di Meo

  DOI：10.1021/jm00166a003

  日期：1990.4

  The synthesis and cardiac electrophysiological activity of 18 N-substituted imidazolylbenzamides or benzene-sulfonamides are described. Compounds 6a,d,f-k and 11 exhibited potency in the in vitro Purkinje fiber assay comparable to that of N-[2-(diethylamino)ethyl]-4- [(methylsulfonyl)amino]benzamide (1, sematilide), a potent selective class III agent which is undergoing clinical trials. These data

  描述了18种N-取代的咪唑基苯甲酰胺或苯磺酰胺的合成和心脏电生理活性。化合物6a，d，fk和11在体外Purkinje纤维测定中显示出与N- [2-（二乙基氨基）乙基] -4-[（甲基磺酰基）氨基]苯甲酰胺（1，sematilide）相当的效能。正在进行临床试验的III类药物。这些数据表明1H-咪唑-1-基部分是甲基磺酰氨基的可行替代物，用于在N-取代的苯甲酰胺系列中产生III类电生理活性。在两个折返性心律不齐的体内模型中进一步研究了N- [2-（二乙氨基）乙基] -4-（1H-咪唑-1-基）苯甲酰胺二盐酸盐（6a），显示出与1。
• ALPHA-CARBOLINE DERIVATIVES AND METHODS FOR PREPARATION THEREOF
  申请人：Mizuno Masahiro

  公开号：US20090326229A1

  公开（公告）日：2009-12-31

  To provide methods for preparing alpha-carboline derivatives in few steps, as well as conveniently and industrially advantageously. A method for preparation of a compound represented by Formula (II) or a salt thereof, comprising subjecting a compound represented by Formula (I) or a salt thereof to a ring closure reaction in the presence of a palladium catalyst, a ligand, and a base; a method for preparation of a compound represented by Formula (IX) or a salt thereof, comprising subjecting a compound represented by Formula (VII) or a salt thereof to a ring closure reaction in the presence of a palladium catalyst, a ligand, and a base, and subsequently to an aromatization reaction; and methods for preparation of compounds represented by Formulae (XV), (XVII), and (XIX) or a salt thereof, comprising subjecting respective compounds represented by Formulae (II) and (IX) or a salt thereof to a reaction for introducing a leaving group when necessary, and subsequently to a coupling reaction: wherein the symbols respectively represent the same meaning as defined in the present specification.

  提供几步制备α-咔啉衍生物的方法，以及方便和具有工业优势的方法。一种制备式（II）化合物或其盐的方法，包括在钯催化剂、配体和碱的存在下，将式（I）化合物或其盐进行环闭合反应；一种制备式（IX）化合物或其盐的方法，包括在钯催化剂、配体和碱的存在下，将式（VII）化合物或其盐进行环闭合反应，然后进行芳构化反应；以及制备式（XV）、（XVII）和（XIX）化合物或其盐的方法，包括在必要时将式（II）和（IX）化合物或其盐分别进行引入离去基团的反应，然后进行偶联反应：其中符号分别表示本说明书中定义的相同含义。
• PROCESS FOR THE SYNTHESIS OF HYDROXY AROMATIC ACIDS
  申请人：Ritter Joachim C.

  公开号：US20080139843A1

  公开（公告）日：2008-06-12

  Hydroxy aromatic acids are produced in high yields and high purity (>95%) from halogenated aromatic acids in a reaction mixture containing a copper source and a ligand that coordinates to copper.

  含卤素的芳香酸在反应混合物中，加入铜源和配位于铜的配体，可以高产高纯度（> 95％）地制备羟基芳香酸。
• Regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
  申请人：ALONSO Jorge

  公开号：US20100216988A1

  公开（公告）日：2010-08-26

  The present invention relates to a process for the regioselective synthesis of compounds of the formula I, wherein R1; R2; R3; R4; J1; J2; J3; J4 and G have the meanings indicated in the claims. The present invention provides a direct metal, e.g. palladium or copper, catalyzed, regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted amides.

  本发明涉及一种用于选择性合成式I化合物的过程，其中R1; R2; R3; R4; J1; J2; J3; J4和G具有声明中所示的含义。本发明提供了一种直接金属，例如钯或铜，催化的、选择性区域的过程，从2-卤代硝基芳烃和N-取代酰胺开始，合成广泛的非对称、多功能的N-取代苯并咪唑或氮杂苯并咪唑式I化合物。